Colgate-Palmolive financials
$86.46−0.07%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.36B | $5.32B | $5.23B | $5.13B | $5.11B | $4.91B | $4.95B | $5.03B | $5.06B | $5.07B | $4.95B | $4.92B |
| Gross profit | $3.30B | $3.23B | $3.15B | $3.05B | $3.07B | $2.99B | $2.98B | $3.07B | $3.07B | $3.04B | $2.95B | $2.88B |
| Gross margin | 61.5% | 60.6% | 60.2% | 59.4% | 60.1% | 60.8% | 60.3% | 61.1% | 60.6% | 60.0% | 59.6% | 58.5% |
| Operating income | $1.02B | $964.0M | $150.0M | $1.06B | $1.08B | $1.08B | $989.0M | $1.07B | $1.10B | $1.05B | $1.07B | $1.03B |
| Net income | $693.0M | $646.0M | -$37.0M | $735.0M | $743.0M | $690.0M | $739.0M | $737.0M | $731.0M | $683.0M | $718.0M | $708.0M |
| Net margin | 12.9% | 12.1% | −0.7% | 14.3% | 14.5% | 14.1% | 14.9% | 14.6% | 14.5% | 13.5% | 14.5% | 14.4% |
| Diluted EPS | $0.86 | $0.80 | $-0.05 | $0.91 | $0.91 | $0.85 | $0.90 | $0.90 | $0.89 | $0.83 | $0.87 | $0.86 |
| EBITDA | $1.17B | $1.12B | $1.24B | $1.22B | $1.23B | $1.22B | $1.14B | $1.22B | $1.26B | $1.20B | $1.07B | $1.17B |
| Operating cash flow | $995.0M | $747.0M | $1.45B | $1.26B | $884.0M | $600.0M | $1.27B | $1.17B | $990.0M | $681.0M | $1.14B | $1.15B |
| Free cash flow | $867.0M | $609.0M | $1.28B | $1.11B | $776.0M | $476.0M | $1.08B | $1.03B | $873.0M | $555.0M | $939.0M | $991.0M |
| Diluted shares | 801.8M | 805.1M | 805.9M | 810.2M | 813.3M | 815.0M | 820.7M | 822.5M | 823.7M | 825.9M | 825.2M | 827.3M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $1.37B | $1.33B | $1.29B | $1.28B | $1.22B | $1.11B |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $7.86B | $7.97B | $7.99B | $8.42B | $8.76B | $8.27B |
| Total assets | $16.79B | $16.61B | $16.33B | $17.51B | $17.47B | $16.65B |
| Total liabilities | $16.22B | $16.12B | $15.96B | $16.27B | $16.42B | $15.91B |
| Shareholders' equity | $566.0M | $486.0M | $365.0M | $1.24B | $1.05B | $733.0M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology